A new human cell line with pre-B cell phenotype and t(5;12)

Area of Science:

• Hematology
• Cell Biology
• Oncology

Background:

• Acute lymphoblastic leukemia (ALL) is a heterogeneous malignancy.
• Characterization of specific cell lines aids in understanding leukemia subtypes.
• The pre-B cell stage is critical in B-cell development and leukemia.

Purpose of the Study:

• To establish and characterize a new human pre-B cell line (LR10.6).
• To investigate the immunophenotype and genetic features of the LR10.6 cell line.
• To explore the response of LR10.6 cells to specific stimuli.

Main Methods:

• Establishment of a cell line from bone marrow of a child with B-lineage ALL.
• Immunophenotypic analysis using flow cytometry for various cell surface and intracellular markers.
• Cytogenetic analysis to identify chromosomal abnormalities.
• Stimulation of cells with phorbol-12 myristate 13-acetate (PMA) to assess antigen expression changes.

Main Results:

• The LR10.6 cell line exhibits a pre-B cell phenotype with nuclear TdT, cytoplasmic Ig lambda, and membrane mu-chain expression.
• Cells express activation antigens (CD69, CD71), adhesion molecules (CD54, CD50, CD56), and CD117, but lack myeloid/T-cell markers.
• A translocation t(5;12)(q31;p13) involving IL3 and TEL/ETV6 genes was identified.
• PMA treatment up-regulated CD69 and down-regulated CD117, but did not induce CD20.

Conclusions:

• The LR10.6 cell line represents a valuable pre-B cell model for studying B-lineage ALL.
• The identified t(5;12) translocation provides insights into the genetic landscape of this leukemia subtype.
• The differential response to PMA highlights specific signaling pathways and differentiation potential within the cell line.